REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Voronoi, Inc. (Incheon) (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Voronoi, Inc. Profile Updated: July 04, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Voronoi, Inc. is engaged in developing of small molecule inhibitors of kinases using kinase profiling and molecular modeling. The company was incorporated in 2015 and is based in Incheon, South Korea.

Headquarters
S-dong, 18th Floor, 32, Songdogwahak-ro Yeonsu-gu Incheon
Incheon; Incheon;

Contact Details: Purchase the Voronoi, Inc. (Incheon) report to view the information.

Basic Information
Total Employees:
Purchase the Voronoi, Inc. (Incheon) report to view the information.
Outstanding Shares:
Purchase the Voronoi, Inc. (Incheon) report to view the information.
Registered Capital:
Purchase the Voronoi, Inc. (Incheon) report to view the information.
Incorporation Date:
February 24, 2015
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Company Performance
Financial values in the chart are available after Voronoi, Inc. (Incheon) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-34.02%▼
Total operating revenue
-34.02%▼
Operating profit (EBIT)
-63.81%▼
EBITDA
-76.31%▼
Net Profit (Loss) for the Period
-21.51%▼
Total assets
52.84%▲
Total equity
158.12%▲
Operating Profit Margin (ROS)
-87.74%▼
Net Profit Margin
-76.82%▼
Return on Equity (ROE)
36.56%▲
Debt to Equity Ratio
-59.44%▼
Quick Ratio
2.56%▲
Cash Ratio
-0.31%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo